// App-Quantinova.ai

63 : Evaluation of circulating tumor cells (CTCs) enumeration and 18F-Choline positron emission tomography/computed tomography (FCH PET/CT) as early efficacy response biomarkers in metastatic castration-resistant prostate cancer (CRPC) patients (pts) treated with abiraterone acetate.

Researchers

Presenter

  • Sylvestre Le Moulec

Principal Investigators

  • Christophe Massard

  • Eric Gontier

  • Francoise Farace

  • Cyrus Chargari

  • Philippe Vielh

  • Olivier Aupee

  • Lionel Vedrine

  • Herve Foehrenbach

  • Karim Fizazi

Medical Centers

  • Val-de-Grace Hospital, Paris, France

  • Institut Gustave-Roussy, Villejuif, France

  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France

  • HIA Val de Grace, Paris, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Metastatic castration-resistant prostate cancer

  • Solid malignancies

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • CB-7598

  • Prednisone

  • Docetaxel

  • Choline bitartrate

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved